Total Payments
$1,762
2024 Payments
$350.79
Companies
13
Transactions
104
Medicare Patients
2,645
Medicare Billing
$208,382
Payment Breakdown by Category
Food & Beverage$1,762 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,762 | 104 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $426.05 | 43 | $0 (2022) |
| Janssen Biotech, Inc. | $405.06 | 29 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $371.00 | 1 | $0 (2020) |
| ABBVIE INC. | $178.13 | 15 | $0 (2024) |
| Galderma Laboratories, L.P. | $138.02 | 3 | $0 (2024) |
| LEO Pharma Inc. | $87.74 | 5 | $0 (2023) |
| Incyte Corporation | $48.10 | 2 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $21.85 | 1 | $0 (2024) |
| Amgen Inc. | $20.92 | 1 | $0 (2024) |
| Verrica Pharmaceuticals Inc. | $18.54 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $350.79 | 23 | ABBVIE INC. ($144.69) |
| 2023 | $217.67 | 13 | Janssen Biotech, Inc. ($151.72) |
| 2022 | $208.00 | 17 | Janssen Biotech, Inc. ($145.78) |
| 2021 | $119.78 | 7 | Janssen Biotech, Inc. ($36.06) |
| 2020 | $394.73 | 2 | MERZ NORTH AMERICA, INC. ($371.00) |
| 2019 | $140.61 | 21 | Allergan Inc. ($124.21) |
| 2018 | $264.94 | 17 | Allergan Inc. ($132.90) |
| 2017 | $65.21 | 4 | Allergan Inc. ($52.61) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $7.83 | General |
| 10/28/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $2.24 | General |
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.60 | General |
| Category: Dermatology | ||||||
| 08/07/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: DERMATOLOGY | ||||||
| 08/07/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $14.19 | General |
| 07/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Inflammation | ||||||
| 06/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: IMMUNOLOGY | ||||||
| 05/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Immunology | ||||||
| 04/25/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $6.12 | General |
| 04/05/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: IMMUNOLOGY | ||||||
| 04/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Immunology | ||||||
| 04/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: IMMUNOLOGY | ||||||
| 04/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.84 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Immunology | ||||||
| 02/15/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $7.17 | General |
| 01/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Immunology | ||||||
| 01/19/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/24/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Immunology | ||||||
| 11/13/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 592 | 1,011 | $198,725 | $50,543 |
| 2022 | 9 | 700 | 1,116 | $221,965 | $53,520 |
| 2021 | 9 | 711 | 1,114 | $233,020 | $58,390 |
| 2020 | 9 | 642 | 970 | $201,090 | $45,929 |
Total Patients
2,645
Total Services
4,211
Medicare Billing
$208,382
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 148 | $33,300 | $14,009 | 42.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 137 | 170 | $33,150 | $11,243 | 33.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 92 | 123 | $43,050 | $9,585 | 22.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 90 | 128 | $38,400 | $5,120 | 13.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 21 | $7,350 | $3,089 | 42.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 32 | 33 | $16,500 | $3,028 | 18.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 30 | 51 | $8,925 | $2,168 | 24.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 59 | 325 | $16,250 | $1,784 | 11.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 12 | $1,800 | $517.22 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 151 | 185 | $41,625 | $16,028 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 140 | 163 | $31,815 | $10,260 | 32.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 109 | 136 | $47,600 | $10,226 | 21.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 117 | 155 | $46,500 | $6,087 | 13.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 32 | 36 | $18,000 | $3,104 | 17.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 19 | 22 | $7,700 | $3,016 | 39.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 37 | 47 | $8,225 | $2,054 | 25.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 78 | 353 | $17,650 | $1,973 | 11.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 19 | $2,850 | $771.81 | 27.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 183 | 229 | $52,525 | $21,592 | 41.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 101 | 123 | $43,050 | $8,843 | 20.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 118 | 133 | $26,145 | $8,055 | 30.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 55 | 61 | $30,500 | $5,598 | 18.4% |
| 17000 | Destruction of skin growth | Office | 2021 | 109 | 140 | $42,000 | $5,542 | 13.2% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2021 | 18 | 24 | $8,400 | $3,191 | 38.0% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 34 | 60 | $10,500 | $2,737 | 26.1% |
About Dr. Lynn Klein, M.D
Dr. Lynn Klein, M.D is a Dermatology healthcare provider based in Bala Cynwyd, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720147861.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lynn Klein, M.D has received a total of $1,762 in payments from pharmaceutical and medical device companies, with $350.79 received in 2024. These payments were reported across 104 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,762).
As a Medicare-enrolled provider, Klein has provided services to 2,645 Medicare beneficiaries, totaling 4,211 services with total Medicare billing of $208,382. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Bala Cynwyd, PA
- Active Since 12/06/2006
- Last Updated 02/13/2017
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720147861
Products in Payments
- TREMFYA (Drug) $405.06
- XEOMIN (Biological) $371.00
- BOTOX COSMETIC (Biological) $86.66
- RINVOQ (Biological) $71.26
- ENSTILAR (Drug) $55.23
- OPZELURA (Drug) $48.10
- RHOFADE (Drug) $34.38
- ADBRY (Biological) $32.51
- SKYRIZI (Biological) $28.83
- DAXXIFY (Drug) $21.85
- HUMIRA (Biological) $21.24
- Otezla (Drug) $20.92
- YCANTH (Drug) $18.54
- ORACEA (Drug) $16.40
- XTRAC (Device) $15.92
- DUPIXENT (Biological) $15.58
- ARAZLO (Drug) $14.82
- DYSPORT (Biological) $14.19
- BOTOX (Biological) $12.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.